Breakingviews: Novartis Makes a Deal That Should Go Down Easy

The drugmaker’s acquisition of Advanced Accelerator Applications is not coming cheap, but should provide Novartis with a respectable return on its investment.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *